DVN
32
-4
DOW
39
-4
ETR
52
6
HCA
55
5
FSLR
40
-3
STZ
44
-6
GILD
54
4
BF.B
47
-4
EMN
60
-2
TSCO
75
3
CHRW
51
-3
CSCO
58
-2
PSX
65
-5
HRL
32
-4
LYB
37
-4
VRSK
42
4
DVA
59
3
MTCH
55
-2
INTC
54
-2
ISRG
52
2
DVN
32
-4
DOW
39
-4
ETR
52
6
HCA
55
5
FSLR
40
-3
STZ
44
-6
GILD
54
4
BF.B
47
-4
EMN
60
-2
TSCO
75
3
CHRW
51
-3
CSCO
58
-2
PSX
65
-5
HRL
32
-4
LYB
37
-4
VRSK
42
4
DVA
59
3
MTCH
55
-2
INTC
54
-2
ISRG
52
2
Financhill
Back

Direxion Daily S&P Biotech Bear 3X Shares Vs. Nektar Therapeutics Industry Stock Comparison

Sell
19

LABD
Direxion Daily S&P Biotech Bear 3X Shares

Last Price:
$6.62
Seasonality Move:
2.86%
Buy
54

NKTR
Nektar Therapeutics

Last Price:
$23.83
Seasonality Move:
3.38%
Sell
19
Direxion Daily S&P Biotech Bear 3X Shares (LABD) is a Sell

Is Direxion Daily S&P Biotech Bear 3X Shares a Buy, Sell or Hold?

  • The current Direxion Daily S&P Biotech Bear 3X Shares [LABD] share price is $6.13. The Score for LABD is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • LABD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
54
Nektar Therapeutics (NKTR) is a Buy

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $24.41. The Score for NKTR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

LABD Stock Price Chart

What is Direxion Daily S&P Biotech Bear 3X Shares's stock price today?

  • The Direxion Daily S&P Biotech Bear 3X Shares share price today is $6.13
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LABD is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $24.41
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.

LABD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.55 Buy
Relative Strength Index (14 RSI): 34.85 Sell
Chaikin Money Flow: -12809333 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.66 - 7.58) Sell
Bollinger Bands (100): (6.88 - 9.76) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.02 Buy
Relative Strength Index (14 RSI): 63.8 Buy
Chaikin Money Flow: 4197 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.12 - 26.32) Buy
Bollinger Bands (100): (7.51 - 18.15) Buy

LABD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.63 Sell
20-day SMA: 7.13 Sell
50-day SMA: 7.86 Sell
200-day SMA: 7.33 Sell
8-day EMA: 4.51 Buy
20-day EMA: 2.5 Buy
50-day EMA: 1.15 Buy
200-day EMA: 0.31 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.3 Buy
20-day SMA: 20.35 Buy
50-day SMA: 14.3 Buy
200-day SMA: 14.58 Buy
8-day EMA: 17.41 Buy
20-day EMA: 9.54 Buy
50-day EMA: 4.38 Buy
200-day EMA: 1.18 Buy

Direxion Daily S&P Biotech Bear 3X Shares Earnings Growth & LABD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.86 per share, and an increase next year of $0.01 per share.

Direxion Daily S&P Biotech Bear 3X Shares Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):